Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Altmueller, Janine Dr.med. (1) Bunse, Mario Dr. (1) Daniel, Peter Prof. Dr. (1) Kammertöns, Thomas Dr. (5) Pezzutto, Antonio Prof. Dr. (3) Uckert, Wolfgang Prof. Dr. (2) (-) Blankenstein, Thomas Prof. Dr. (30) (-) Kopp, Joachim Dr. (1) (-) Willimsky, Gerald Dr. (8) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) (-) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) (-) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) (-) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) (-) 2013 (12) 2014 (3) 2015 (4) 2016 (4) 2017 (6) 2018 (5) 2019 (7) 2020 (2) 2021 (4) 2022 (12) 2023 (10) 2024 (3) Developmental Biology / Signal Transduction (1) Experimental Ultrahigh-Field MR (1) Genetics of Metabolic and Reproductive Disorders (2) Magnetic Resonance (1) (-) Molecular Immunology and Gene Therapy (31) Translational Oncology of Solid Tumors (1) 31 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Kopp, Joachim Dr.Willimsky, Gerald Dr.Molecular Immunology and Gene Therapy1997200220072013 Sort: Result score Newest to oldest Oldest to newest April 01, 2002 / Trends Immunol Cross-priming versus cross-tolerance: are two signals enough? T. Blankenstein T. Schueler June 03, 2002 / J Exp Med Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction Z. Qin H.J. Kim J. Hemme T. Blankenstein May 15, 2002 / Canc Res Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors Z. Qin C. Harders X. Cao C. Huber T. Blankenstein B. Seliger January 15, 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein February 08, 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel March 07, 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky February 05, 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein March 01, 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein May 01, 2013 / Canc Res Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens J Zhang L Chen X Liu T. Kammertoens T. Blankenstein Z. Qin April 15, 2013 / Canc Cell It's the peptide-MHC affinity, stupid T. Kammertoens T. Blankenstein Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
April 01, 2002 / Trends Immunol Cross-priming versus cross-tolerance: are two signals enough? T. Blankenstein T. Schueler
June 03, 2002 / J Exp Med Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction Z. Qin H.J. Kim J. Hemme T. Blankenstein
May 15, 2002 / Canc Res Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors Z. Qin C. Harders X. Cao C. Huber T. Blankenstein B. Seliger
January 15, 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein
February 08, 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
March 07, 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky
February 05, 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
March 01, 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein
May 01, 2013 / Canc Res Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens J Zhang L Chen X Liu T. Kammertoens T. Blankenstein Z. Qin